Cardiovascular Safety of Sitagliptin in Patients With T2DMCardiovascular Safety of Sitagliptin in Patients With T2DM

What is the effect of this DPP-4 inhibitor on cardiovascular outcomes?

Source: Medscape Today Headlines - May 20, 2013 Category: Consumer Health News Tags: Journal Article Source Type: news